Oral. Tablets should be swallowed whole with water, preferably on an empty stomach or at least 30 minutes before food, or 2 hours after food, to ensure optimal absorption and prevent degradation by stomach acid.

Serratiopeptidase acts by hydrolyzing proteins, breaking down inflammatory mediators like bradykinin, histamine, and serotonin. It also helps to liquefy exudates and reduce swelling by promoting the drainage of fluid from inflamed tissues. Its fibrinolytic activity assists in dissolving blood clots and tissue debris.

• •Hypersensitivity to serratiopeptidase or any component of the formulation
• •Patients with bleeding disorders or those on anticoagulant therapy
• •Severe liver or kidney impairment

Store in a cool, dry place, below 30°C. Protect from light and moisture. Keep out of reach of children.

Symptoms of overdose are generally mild, but may include gastrointestinal upset, nausea, vomiting, or increased bleeding risk. Management is symptomatic and supportive. No specific antidote.

Limited data available. Should be used with caution during pregnancy and lactation only if clearly needed and potential benefits outweigh risks. Consult a doctor.